Skip to content

Cannabis effects on driving longitudinal control with and without alcohol.

Rebecca L Hartman, Timothy L Brown, Gary Milavetz, Andrew Spurgin, Russell S Pierce, David A. Gorelick, Gary R Gaffney, Marilyn A. Huestis

Journal of Applied Toxicology November 2016 DOI: 10.1002/jat.3295 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Within-subject experimental study Longitudinal Peer reviewed
Sample size 18
Population Current occasional cannabis smokers (at least once in the last 3 months, no more than 3 days per week)
Interventions Vaporized cannabis Alcohol
Dose 500 mg placebo, low (2.9%), or high (6.7%) THC vaporized cannabis; placebo or low-dose alcohol
Duration Drives 0.5-1.3 h post-inhalation; blood and breath samples at 0.17, 0.42, 1.4, and 2.3 h
Topics Cannabis
Keywords Alcohol Blood Driving Speed
Key findings Blood THC concentration was associated with decreased mean speed, increased percent time below the speed limit, and increased following distance during headway maintenance. Breath alcohol was associated with increased speed variability and more time above the speed limit, while THC was not. The authors report a less-than-additive THC-by-alcohol interaction on speeding, suggesting cannabis mitigated drivers' tendency to drive faster with alcohol.

Abstract

Although evidence suggests cannabis impairs driving, its driving-performance effects are not fully characterized. We aimed to establish cannabis' effects on driving longitudinal control (with and without alcohol, drivers' most common drug combination) relative to psychoactive ∆(9) -tetrahydrocannabinol (THC) blood concentrations. Current occasional (≥1×/last 3 months, ≤3 days per week) cannabis smokers drank placebo or low-dose alcohol, and inhaled 500 mg placebo, low (2.9%), or high (6.7%) THC vaporized cannabis over 10 min ad libitum in separate sessions (within-subject, six conditions). Participants drove (National Advanced Driving Simulator, University of Iowa) simulated drives 0.5-1.3 h post-inhalation. Blood and breath alcohol samples were collected before (0.17 and 0.42 h) and after (1.4 and 2.3 h) driving. We evaluated the mean speed (relative to limit), standard deviation (SD) of speed, percent time spent >10% above/below the speed limit (percent speed high/percent speed low), longitudinal acceleration, and ability to maintain headway relative to a lead vehicle (headway maintenance) against blood THC and breath alcohol concentrations (BrAC). In N=18 completing drivers, THC was associated with a decreased mean speed, increased percent speed low and increased mean following distance during headway maintenance. BrAC was associated with increased SD speed and increased percent speed high, whereas THC was not. Neither was associated with altered longitudinal acceleration. A less-than-additive THC*BrAC interaction was detected in percent speed high (considering only non-zero data and excluding an outlying drive event), suggesting cannabis mitigated drivers' tendency to drive faster with alcohol. Cannabis was associated with slower driving and greater headway, suggesting a possible awareness of impairment and attempt to compensate. Copyright © 2016 John Wiley & Sons, Ltd.

Comparable studies

Other experimental studies on cannabis, most cited first.

Study Year Design Participants
Smoked Cannabis' Psychomotor and Neurocognitive Effects in Occasional and Frequent Smokers Occasional (<2x/week) and frequent (≥4x/week) cannabis smokers 2015 Controlled within-subjects study n = 25
Dissociable effects of cannabis with and without cannabidiol on the human brain’s resting-state functional connectivity Healthy volunteers experienced with cannabis but not regular users 2019 Within-subjects experimental design n = 17
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects? Young cannabis users 2018 Observational study (naturalistic, within-subject counterbalanced design) n = 410
Cannabis Essential Oil: A Preliminary Study for the Evaluation of the Brain Effects Healthy volunteers 2018 Experimental study n = 5
Coming off cannabis: a cognitive and magnetic resonance imaging study in patients with multiple sclerosis Patients with multiple sclerosis who began using cannabis after disease onset, used it... 2019 Quasi-experimental study with odd-even allocation n = 40

Citations in the library

Explore topics